FDA Inspection 1086970 — LabCorp Bioanalytical Services, LLC
The FDA completed an inspection of LabCorp Bioanalytical Services, LLC on Feb 15, 2019 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Indianapolis, IN (United States)
Additional Details
Bioanalytical BA/BE